CTRI/2023/05/052417招募中2 期
Study of efficacy of thalidomide in complicated tubercular infection of central nervous system
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Possible, probable, or definite TBM as diagnosed by Marais et al criteria.
- •Patients already on standard ATT and steroid protocol for CNS TB who develop complications in the form of paradoxical worsening like opto-chiasmatic syndrome, spinal arachnoiditis, increase in tuberculomas, exudates or clinical worsening etc.
- •Patients willing to be followed up for at least 6 months for assessment.
排除标准
- •1.Patients who are either HIV positive or immunocompromised due to some other disease.
- •2.Patients are on immunosuppressive drugs.
- •3.Patients who cannot undergo lumbar puncture or MRI examination.
- •4.Pregnant patients.
- •5.CSF gram stain or/and culture showing microorganisms other than acid fast bacilli.
研究者
相似试验
进行中（未招募）
1 期
Efficacy of thalidomide in the treatment of heavy and frequent nose bleeding in patients affected by hereditary hemorrhagic telangiectasiaSevere recurrent epistaxis in hereditary hemorrhagic telangiectasiaMedDRA version: 14.1Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-004096-36-ITOSPEDALE POLICLINICO S. MATTEO31
招募中
3 期
Thalidomide in COVID19COVID19.disease diagnosis of COVID-19 confirmed by laboratory testing.U07.1IRCT20170207032444N3Esfahan University of Medical Sciences60
已完成
3 期
Effect of Thalidomide in Covid 19 pneumoniaPneumonia caused by Coronavirus 2019, COVID19.Coronavirus infection, unspecifiedB34.2IRCT20200428047232N1Esfahan University of Medical Sciences60
尚未招募
不适用
Addition of oral thalidomide to standard antitubercular regimen for initial 2 months improves the outcome in patients of tubercular meningitis as compared to standard therapy alone.CTRI/2020/08/027438AIIMS Bhubaneswar
尚未招募
3 期
se of medicines- Hydroxyurea and thalidomide for children suffering from thalassemiaCTRI/2023/12/060945ICMR, Delhi